FEATURED STORY

New technology to boost HIV/AIDS research in Kenya

Share
Dr Oscar Diomande, MD, MAGBIO Solutions Kenya (extreme right) demonstrates the use of the Blood Statis tube to Dr. George Gichuki, CEO, Africa Genomics Centre (Middle) and Dr. Hyacinth Ntchobo, Global CEO, MAGBIO Genomics Solutions.
Share

HIV/AIDS research received a major boost on October 25 following the commissioning of the latest technology in blood sample collection in the country.

MagBio Solutions Africa (MGSA), a health research company headquartered in Nairobi launched the Blood STATIS DNA technology, a plastic evacuated tube that contains additives that help in slowing down platelets from clumping together to form a clot.

The tube is tailored to stabilize, transport and store blood at room temperature for upto 21 days which eliminates the need for costly cold chain transportation of blood samples.

Going forward, this means that it will be easier to collect and preserve blood for HIV testing for longer periods without possible contamination of the samples.

It will also assist researchers in viral load (number of HIV viruses in the bloodstream) monitoring for patients suffering from HIV/AIDS and easy follow up as Blood STASIS tubes allow stabilization of the HIV virus in blood for 21 days.

Kenya is the first country in Africa to launch this technology which is a major boost for the country’s fight against HIV/AIDS.

MGSA has already obtained the requisite approvals for the technology from the Pharmacy and Poisons Board of Kenya and the Kenya Medical Research Institute (KEMRI).

Speaking during the launch which was attended by National AIDS and STI control Programme (NASCOP) Head Dr. Kigen Barmasai as well as senior scientists and researchers from KEMRI and the University of Nairobi (UON), Dr. Hyacinth Ntchobo, global MGSA CEO said the system allows flexibility and more efficiency in processing high volume blood samples for HIV.

He challenged scientists in Kenya to deploy medical technology in the fight against HIV/AIDS like the United States and Europe is doing at the moment.

Dr. Ntchobo added that the company is working closely with research institutions in Kenya and the rest of Africa to develop customized products or technology as a solution to address scientific challenges.

He further said the company plans to set up a production factory for its output in Kenya in the near future to serve the region.

5 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

PAST ARTICLES AND INSIGHTS

Related Articles
Limuru tea shares
BUSINESSSTOCKS

NSE Lists Additional Williamson, Kapchorua Shares: The Game Plan

NSE (Nairobi Securities Exchange) has announced the admission of additional ordinary shares...

Food Prices had a mixed movement in October
BUSINESSECONOMYFEATURED STORY

Kenya Monthly Inflation Rate Up 0.2% in October

Kenya Consumer Price Index(CPI), which measures change over time in retail prices...

KenGen has been a target of speculative activity at the NSE
BUSINESSECONOMYFEATURED STORYMARKETSNEWSSTOCKS

KenGen Records an End-Year Net Profit of 10.5 Bn

KenGen (Kenya Electricity Generating Company), the state-owned listed power generator has posted...

Equity Bank CEO Centre Dr James Mwangi with other top bank officials during the Q3 Results Briefing
BUSINESSFEATURED STORYNEWS

Equity Group Third Quarter Net Earnings Up 32% to KSh 54.1 Bn

Equity Group Holdings Plc net earnings for the period ended 30th September...